The University of California, Irvine Medical Center is a major research hospital located in Orange, California. It is the teaching hospital for the University of California, Irvine School of Medicine.

There are 411 beds in University of California - Irvine Medical Center.

During the past decade, University of California - Irvine Medical Center conducted 211 clinical trials. In the 10-year time frame, 211 clinical trials started and 99 clinical trials were completed, i.e. on average, 46.9% percent of trials that started reached the finish line to date. In the past 5 years, 109 clinical trials started and 62 clinical trials were completed. i.e. 56.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California - Irvine Medical Center" #1 sponsor was "University of California, Irvine" with 89 trials, followed by "Pfizer" with 26 trials sponsored, "Hoffmann-La Roche" with 16 trials sponsored, "National Cancer Institute (NCI)" with 13 trials sponsored and "Amgen" with 13 trials sponsored. Other sponsors include 262 different institutions and companies that sponsored additional 197 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California - Irvine Medical Center" #1 collaborator was "University of California, Irvine" with 10 trials as a collaborator, "Beckman Laser Institute University of California Irvine" with 9 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "National Cancer Institute (NCI)" with 7 trials as a collaborator and "Pfizer" with 6 trials as a collaborator. Other collaborators include 272 different institutions and companies that were collaborators in the rest 206 trials.

According to Clinical.Site data, the most researched conditions in "University of California - Irvine Medical Center" are "HIV Infections" (16 trials), "Prostate Cancer" (14 trials), "Alzheimer's Disease" (10 trials), "Ovarian Cancer" (9 trials) and "Acute Myeloid Leukemia" (6 trials). Many other conditions were trialed in "University of California - Irvine Medical Center" in a lesser frequency.

Most popular intervention types in "University of California - Irvine Medical Center" are "Drug" (268 trials), "Device" (52 trials), "Biological" (44 trials), "Other" (41 trials) and "Procedure" (31 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "placebo" (9 trials), "Atezolizumab" (8 trials), "Pembrolizumab" (8 trials) and "laboratory biomarker analysis" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of California - Irvine Medical Center" are 346 trials for "All" genders, 53 trials for "Female" genders and 23 trials for "Male" genders.

Currently, there are NaN active trials in "University of California - Irvine Medical Center". undefined are not yet recruiting, 67 are recruiting, 55 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 212 completed trials in University of California - Irvine Medical Center, 3 suspended trials, and 50 terminated clinical trials to date.

Out of the total trials that were conducted in University of California - Irvine Medical Center, 56 "Phase 1" clinical trials were conducted, 125 "Phase 2" clinical trials and 119 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 70 trials that are defined as “Not Applicable".

University of California - Irvine Medical Center has several departments that took part in Clinical trials: "UC Irvine Health/Chao Family Comprehensive Cancer Center" - 419 trials, "UC Irvine Health Cancer Center-Newport" - 29 trials, "University of California Irvine - ALS & Neuromuscular Center" - 11 trials, "University of California Irvine Medical Center - Infectious Disease" - 4 trials, "H. H. Chao Comprehensive Digestive Disease Center" - 3 trials, "University of California at Irvine Medical Center; Department of Oncology" - 2 trials, "UCI Medical Center- Outpatient Pharmacy" - 2 trials